** Iridex Corp IRIX.O down ~16 pct at $6.50 premarket
after medical device maker prices its follow-on at a deep
discount
** Stock 2nd biggest faller on Nasdaq .IXIC before the
bell
** Co offers 1.67 mln shares at $6, a 23 pct discount to
stock's Thurs close, for gross raise of $10 mln urn:newsml:reuters.com:*:nGNX9DgLn5
** Offering represents 20 pct of co's ~8.5 mln shares of
free float (TR data) and more than 100 days of trading volume
based on 90-DMA of ~16k shares
** Iridex says intends to use net proceeds for working
capital, general purposes, and may use portion for licensing or
acquiring intellectual property or technology for its products
** Stifel sole bookrunner, Roth Capital lead manager
** IRIX shares are up ~2 pct this year, following a 46 pct
fall in 2017
((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 646-223-5017))